T.Man Pharmaceutical Past Earnings Performance
Past criteria checks 3/6
T.Man Pharmaceutical has been growing earnings at an average annual rate of 30.7%, while the Pharmaceuticals industry saw earnings growing at 9.4% annually. Revenues have been growing at an average rate of 13.9% per year. T.Man Pharmaceutical's return on equity is 82.3%, and it has net margins of 19.7%.
Key information
30.7%
Earnings growth rate
10.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | 13.9% |
| Return on equity | 82.3% |
| Net Margin | 19.7% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How T.Man Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,197 | 433 | 505 | 0 |
| 30 Jun 24 | 2,130 | 419 | 492 | 0 |
| 31 Mar 24 | 2,055 | 425 | 472 | 0 |
| 31 Dec 23 | 1,980 | 431 | 452 | 0 |
| 30 Sep 23 | 1,903 | 416 | 440 | 0 |
| 30 Jun 23 | 1,982 | 494 | 426 | 0 |
| 31 Mar 23 | 2,003 | 483 | 459 | 0 |
| 31 Dec 22 | 2,025 | 473 | 493 | 0 |
| 31 Dec 21 | 1,263 | 56 | 321 | 0 |
| 31 Dec 20 | 901 | 60 | 254 | 0 |
Quality Earnings: TMAN-R has high quality earnings.
Growing Profit Margin: TMAN-R's current net profit margins (19.7%) are lower than last year (21.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TMAN-R's earnings have grown significantly by 30.7% per year over the past 5 years.
Accelerating Growth: TMAN-R's earnings growth over the past year (4.2%) is below its 5-year average (30.7% per year).
Earnings vs Industry: TMAN-R earnings growth over the past year (4.2%) did not outperform the Pharmaceuticals industry 7.3%.
Return on Equity
High ROE: TMAN-R's Return on Equity (82.3%) is considered outstanding.